Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acorda Therapeutics, Inc.
Acorda Therapeutics, Inc. Announces Exercise of Option by Underwriters
March 2nd, 2008
Acorda Therapeutics, Inc.(R) (the "Company") (NASDAQ: ACOR) announced that the underwriters of its February 2008 public offering of common stock have exercised their entire option to purchase an additional 495,000 shares of common stock. The exercise of the option increases the size of the offering to an aggregate of 3,795,000 shares of common stock. J.P. Morgan Securities Inc. and Deutsche Bank Securities Inc. are acting as joint bookrunning managers of the offering. Information about the offering is available in the prospectus supplement for the offering filed with the Securities and Exchange Commission. A copy of the prospectus supplement, when available, may be...
Source: Pharma Investments, Ventures & Law Weekly (2008-03-02)
|
